Cancer Survivorship Series: Lung Cancer Survivorship - Module 5 is organized by The University of Texas MD Anderson Cancer Center.
Starting Date: February 1, 2023
Ending Date: January 31, 2026
Description:
The National Academy of Medicine, formerly called the Institute of Medicine, recognized cancer survivors faced complex physical and emotional health problems, which are often unmet. As of January 2019, there were over 1.1 million cancer survivors living in Texas. This 5-part series provides an overview of cancer survivorship, including phases of cancer survivorship, current trends and models of survivorship care, and evidence-based practices to reduce long-term sequelae of cancer treatment and the enhance survivorship care delivered.
Objectives:
At the conclusion of this activity, learners will be able to:
• Describe the epidemiology of lung cancer survivors.
• Identify the components of lung cancer survivorship care.
Accreditation:
In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. .
Credit Designation:
The University of Texas MD Anderson Cancer Center designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™.
The University of Texas MD Anderson Cancer Center designates this enduring material will award .75 Nursing Contact Hours.
ABIM Maintenance Of Certification:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to .75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved